<DOC>
	<DOCNO>NCT01949766</DOCNO>
	<brief_summary>This single patient compassionate use protocol determine whether RAVICTI improve bile flow subject previously tolerate therapy Buphenyl .</brief_summary>
	<brief_title>Transition From Buphenyl RAVICTI Therapy Byler Disease</brief_title>
	<detailed_description />
	<mesh_term>Cholestasis , Intrahepatic</mesh_term>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<criteria>Byler Disease Cholestasis Tolerance Buphenyl therapy Allergy/Hypersensitivity RAVICTI</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>